COPD, restrictive syndrome and inflammation.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Thorax

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 15994272PMCID PMC1747448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The nature of small-airway obstruction in chronic obstructive pulmonary disease.

  2004cited by this paper
• High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy.

  2004cited by this paper
• Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis

  2004cited by this paper
• Forced expiratory volume in 1 second and physical activity in the general population.

  2004cited by this paper
• Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

  2004cited by this paper
• Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.

  2004cited by this paper
• Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women’s Heart and Health Study

  2004cited by this paper
• Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination

  2003cited by this paper
• Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

  2003cited by this paper
• Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update

  2003cited by this paper
• Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination.

  2003cited by this paper
• Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

  2003cited by this paper
• Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease

  2003cited by this paper
• Nitric oxide in biological denitrification: Fe/Cu metalloenzyme and metal complex NO(x) redox chemistry.

  2002cited by this paper
• Lung Function and Cardiovascular Risk: Relationship With Inflammation-Sensitive Plasma Proteins

  2002cited by this paper
• Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy.

  2002cited by this paper
• Guidelines for the management of chronic obstructive pulmonary disease.

  2002cited by this paper
• Role of alendronate and risedronate in preventing and treating osteoporosis.

  2001cited by this paper
• Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease.

  2001cited by this paper
• Exhaled nitric oxide is reduced in infants with cystic fibrosis

  2001cited by this paper
• Exhaled and nasal nitric oxide as a marker of pneumonia in ventilated patients.

  2001cited by this paper
• C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.

  2000cited by this paper
• Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children — 1999

  1999cited by this paper
• Cell biology and molecular basis of denitrification.

  1997cited by this paper
• An In Vitro and In Vivo Study of Cytokines in the Acute-Phase Response Associated with Bisphosphonates

  1997cited by this paper
• Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

  1996cited by this paper
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

  1995cited by this paper
• Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.

  1994cited by this paper
• Pamidronate disodium and possible ocular adverse drug reactions.

  1994cited by this paper
• Denitrification: production and consumption of nitric oxide

  1994cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• The pulmonary hemorrhage syndromes.

  1982cited by this paper
• Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage.

  1981cited by this paper

• Alterations of regional alveolar oxygen tension in asymptomatic current smokers: assessment with hyperpolarized (3)He MR imaging.

  2015cites this paper
• Diagnostic Accuracy of Chest Radiography for the Diagnosis of Tuberculosis (TB) and Its Role in the Detection of Latent TB Infection: a Systematic Review

  2014cites this paper
• Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients

  2012cites this paper
• Latent tuberculosis in rheumatoid arthritis: evaluating cellular response and high-resolution computed tomography.

  2012cites this paper
• Latent tuberculosis in rheumatoid arthritis: evaluating cellular response and high-resolution computed tomography.

  2012cites this paper
• Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis

  2009cites this paper